Fosun International Ltd Acquires 2,380 Shares of UnitedHealth Group Incorporated $UNH

Fosun International Ltd grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 46.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,537 shares of the healthcare conglomerate’s stock after acquiring an additional 2,380 shares during the quarter. UnitedHealth Group accounts for approximately 0.6% of Fosun International Ltd’s investment portfolio, making the stock its 13th largest position. Fosun International Ltd’s holdings in UnitedHealth Group were worth $2,351,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Ted Buchan & Co raised its position in UnitedHealth Group by 4.0% in the first quarter. Ted Buchan & Co now owns 5,900 shares of the healthcare conglomerate’s stock valued at $3,090,000 after purchasing an additional 229 shares during the last quarter. Cynosure Group LLC grew its holdings in shares of UnitedHealth Group by 26.7% during the first quarter. Cynosure Group LLC now owns 744 shares of the healthcare conglomerate’s stock worth $390,000 after purchasing an additional 157 shares during the last quarter. Finally, Koss Olinger Consulting LLC bought a new position in UnitedHealth Group in the 1st quarter valued at approximately $521,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $330.61 on Monday. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The firm has a 50 day moving average of $341.79 and a 200-day moving average of $315.98. The company has a market cap of $299.48 billion, a price-to-earnings ratio of 17.26, a price-to-earnings-growth ratio of 2.16 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the company posted $7.15 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Barclays lifted their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Bank of America raised their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 8th. Leerink Partners set a $410.00 target price on UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Finally, Piper Sandler dropped their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 28th. Seventeen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $385.54.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.